CUE
Cue Biopharma·NASDAQ
--
--(--)
--
--(--)
1.22 / 10
Underperform
Technically, CUE is rated 'Underperform' with a 1.22/10 score. The primary concerns are Long Upper Shadow (1.4/10) and Long Lower Shadow (1.04/10) indicators, both historically yielding negative one-month returns (-0.72% and -0.79%, respectively) and low win rates (41.8% and 39.6%). These patterns signal indecision and potential downside pressure. The recent five-day analysis shows two bearish signals and no bullish ones, reinforcing a weak market sentiment. Traders should be cautious of further declines until a clear reversal pattern emerges.
Analysis Checks(0/2)
Long Upper Shadow
Score1.4/10
Win Rate41.75%
Hist. Signals103
Avg Return-0.72%
Score1.4/10
Win Rate41.75%
Hist. Signals103
Avg Return-0.72%
Long Lower Shadow
Score1.04/10
Win Rate39.56%
Hist. Signals91
Avg Return-0.79%
Score1.04/10
Win Rate39.56%
Hist. Signals91
Avg Return-0.79%
Long Upper Shadow
Score1.4/10
Win Rate41.75%
Hist. Signals103
Avg Return-0.72%
Score1.4/10
Win Rate41.75%
Hist. Signals103
Avg Return-0.72%
Long Lower Shadow
Score1.04/10
Win Rate39.56%
Hist. Signals91
Avg Return-0.79%
Score1.04/10
Win Rate39.56%
Hist. Signals91
Avg Return-0.79%
What is the current technical signals for CUE?
- CUE presents a Underperform setup with a Technical Score of 1.22/10. Key technical indicators highlight an RSI of 43.02 and a MACD of 0.00, with the trend anchored by the 50-Day SMA at 0.39. Traders should monitor key support at 0.30 and resistance at 0.33.
